SIREN : 824265490
BIO TOLBIAC is a French company founded 9 years ago, specialized in the sector Supérettes. Based in PARIS (75013), this company of category PME shows in 2025 a net income positive of 253 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/C | N/C | N/C | N/C | N/C | N/C | N/C | N/C |
| Net income | 253 278 € | 40 997 € | 49 118 € | 47 369 € | 108 059 € | 134 250 € | 120 338 € | 113 953 € |
| EBITDA | N/C | N/C | N/C | N/C | N/C | N/C | N/C | N/C |
| Net margin | N/C | N/C | N/C | N/C | N/C | N/C | N/C | N/C |
In 2025, BIO TOLBIAC generates positive net income of 253 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2025: 114 k€ -> 253 k€.
253 278 €
The debt ratio (= Financial debt / Equity x 100) stands at 70%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 34%. The balance between equity and debt is satisfactory.
70.338%
33.587%
19.4%
In 2025, the debt ratio of BIO TOLBIAC (70.34) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2025, the financial autonomy of BIO TOLBIAC (33.6%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
The liquidity ratio (= Current assets / Current liabilities) stands at 156.84. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
156.841
In 2025, the liquidity ratio of BIO TOLBIAC (156.84) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
0 €
0 j
0 j
0 j
Based on 270 transactions of similar company sales in 2025, the value of BIO TOLBIAC is estimated at 1 595 151 € (range 644 834€ - 3 837 545€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 270 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare BIO TOLBIAC with other companies in the same sector:
The revenue of BIO TOLBIAC is not publicly disclosed (confidential accounts filed with INPI).
Yes, BIO TOLBIAC generated a net profit of 253 k€ in 2025.
The headquarters of BIO TOLBIAC is located in PARIS (75013), in the department Paris.
The tax return of BIO TOLBIAC is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
BIO TOLBIAC operates in the sector Supérettes (NAF code 47.11C). See the 'Sector positioning' section above to compare the company with its competitors.